Moderate Cataract
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Long-term Safety & Performance of REVISYON SDS100 in Mild to Moderate Cataract: Extension Study (EB-CE-02) (NCT07246915) | Edinburgh Biosciences Ltd | 2025-10-28 |
Track Moderate Cataract automatically
Every clearance here is in the API, with alerts when new ones post.